Chat message

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

1. 2021-01-11 13:55 Edward C. Holmes open
   I'm going to have to pass because I have a very late meeting the following night that I'll need to rested for. Looking forward to a debrief from Andrew!
2. 2021-01-11 13:57 Andrew Rambaut open
   We have 5 cases of Erik on top of the B117 but they are spontaneous and I doubt driven by antigenic evasion.
3. 2021-01-11 13:57 Edward C. Holmes open
   Bum.
4. 2021-01-11 13:58 Andrew Rambaut open
   I can't make the WHO thing but they have Tulio, Trevor and Marion on the evolution panel. I couldn't do it so I got Oli instead.
5. 2021-01-11 13:58 Andrew Rambaut
   Really struggling to work out what is going on.
6. 2021-01-11 13:59 Andrew Rambaut open
   It seems like all of these lineages are converging to the same set of mutations
7. 2021-01-11 13:59 Edward C. Holmes open
   I hope Tulio gets talking combining classification schemes - that will make a fun 7 hours.
8. 2021-01-11 13:59 Andrew Rambaut open
   Oli will keep him right
9. 2021-01-11 13:59 Robert F. Garry open
   https://www.fox10phoenix.com/news/fda-to-weigh-half-dosing-moderna-covid-19-vaccines-operation-warp-speed-of ficial-says "These are all reasonable questions to consider and evaluate in clinical trials," the FDA said in a statement on Monday." I agree that the UK dosing strategy is wrong - half dosing makes much more sense with both the prime and the boast. The half and third dosing was already considered in a clinical trial - Moderna's Phase Itrial. Two doses of 10 ug gave essentially the same neut and binding as two doses of 30 ug dose. One dose of 100was terrible and caused al ot more adverse reactions so tjhey stopped it. Hate to be cynical, but I think Moderna isprotecting it's newly hatched golden goose.

Full conversation →